Daytrading October 7 afternoon, page-61

@Endless Be good
PAB- watch for the announcement.
Possible groundbreaker in Global Deoxymab cancer breakthrough.For a $4MV Aussie Biotech, globally this could be enormous.
""Patrys believes that Deoxymab, and its sister antibody, 5C6, may have application across a wide range of malignancies such as gliomas, melanomas, prostate, breast, pancreatic and ovarian cancers."(WORLDWIDE).

.8cps being eaten as i type